Publications

Gao, F ; Mora, MC ; Constantinides, M ; Coenon, L ; Multrier, C ; Vaillant, L & al , g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral blood., Oncoimmunology, 2023, 12, 2283353

Sivonen, M ; Sirviö, KA ; Wojciechowski, S ; Kailaanmäki, A ; Kaipainen, S ; Bailey, A & al , Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro., Front Immunol, 2023, 14, 1227064

Sun Myint, A ; Rao, C ; Barbet, N ; Thamphya, B ; Pace-Loscos, T ; Schiappa, R & al , The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750)., Colorectal Dis, 2023, 25, 2160-2169

Modesto, A ; Tougeron, D ; Tremolières, P ; Ronchin, P ; Jouve, AD ; Leignel, DA & al , Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol., BMC Cancer, 2023, 23, 966

Mineur, L ; Plat, F ; Desseigne, F ; Deplanque, G ; Belkacemi, M ; Moureau-Zabotto, L & al , NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU + Lenograstim) Followed by Chemoradiation (CRT) Based 5FU and Oxaliplatin and Surgery., Cancer Res Treat, 2023, ,

Rasola, C ; Laurent-Puig, P ; André, T ; Falcoz, A ; Lepage, C ; Aparicio, T & al , Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.,
Eur J Cancer, 2023, 194, 113321

Mineur, L ; Vazquez, L ; Belkacemi, M ; Toullec, C ; Bentaleb, N ; Boustany, R & al , Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer., Curr Oncol, 2023, 30, 8563-8574

Boige, V ; Blons, H ; François, E ; Ben Abdelghani, M ; Phelip, JM ; Le Brun-Ly, V & al , Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial., JAMA Netw Open, 2023, 6, e2333533

Besse, B ; Felip, E ; Garcia Campelo, R ; Cobo, M ; Mascaux, C ; Madroszyk, A & al , Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1., Ann Oncol, 2023, 34, 920-933

Reina-Ortiz, C ; Mozas, MP ; Ovelleiro, D ; Gao, F ; Villalba, M ; Anel, A , Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells., Int J Mol Sci, 2023, 24,

de Moura, A ; Vuagnat, P ; Renouf, B ; Pierga, JY ; Loirat, D ; Vaflard, P & al , Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program., Sci Rep, 2023, 13, 13427

Campos-Mora, M ; Jacot, W ; Garcin, G ; Depondt, ML ; Constantinides, M ; Alexia, C & al , NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells., Front Immunol, 2023, 14, 1199594

Huober, J ; Weder, P ; Ribi, K ; Thürlimann, B ; Thery, JC ; Li, Q & al, Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.,
JAMA Oncol, 2023, 9, 1381-1389

Hautefeuille, V ; Walter, T ; Do Cao, C ; Coriat, R ; Dominguez, S ; Mineur, L & al , OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel., Eur J Endocrinol, 2023, 189, 281-289

Bollet, MA ; Racadot, S ; Rivera, S ; Arnaud, A ; Bourgier, C , [Breast cancer radiation therapy: Current questions in 2023]., Cancer Radiother, 2023, 27, 524-530

Taïeb, J ; Bouche, O ; André, T ; Le Malicot, K ; Laurent-Puig, P ; Bez, J & al , Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial., JAMA Oncol, 2023, 9, 1356-1363

Calderon, B ; Vazquez, L ; Belkacemi, M ; Pourel, N , Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis., Eur J Med Res, 2023, 28, 233

Racadot, S ; Arnaud, A ; Schiffler, C ; Metzger, S ; Pérol, D ; Kirova, Y , Cicaderma® in radiation-related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT., Clin Transl Radiat Oncol, 2023, 41, 100647

Saez, J ; Bar-Deroma, R ; Bogaert, E ; Cayez, R ; Chow, T ; Clark, CH & al , Universal evaluation of MLC models in treatment planning systems based on a common set of dynamic tests., Radiother Oncol, 2023, 186, 109775

Heudel, PE ; de Montfort, A ; Debieuvre, D ; Chouaid, C ; Carton, M ; Audigier-Valette, C & al , Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors., Lung Cancer, 2023, 182, 107280

Antunes, A ; Alvarez-Vallina, L ; Bertoglio, F ; Bouquin, N ; Cornen, S ; Duffieux, F & al , 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies., MAbs, 2023, 15, 2211692

Bertucci, A ; Cartier, L ; Rollet, A ; Boustany, R ; Hilgers, W , Retrospective Analysis of a Cohort of Patients with Metastatic Bladder Cancer with Metastatic Sites Limited to the Pelvis and Retroperitoneum Treated at a Single Institution between 2009 and 2020., Cancers (Basel), 2023, 15,

Delaby, N ; Barateau, A ; Chiavassa, S ; Biston, MC ; Chartier, P ; Graulières, E & al , Practical and technical key challenges in head and neck adaptive radiotherapy: The GORTEC point of view., Phys Med, 2023, 109, 102568

Rossi, JF ; Bonnet, E ; Castelli, C ; Velensek, M ; Wisniewski, E ; Heraud, S & al , Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study., Vaccines (Basel), 2023, 11,

Rassy, E ; Filleron, T ; Viansone, A ; Lacroix-Triki, M ; Rivera, S ; Desmoulins, I & al , Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials., Breast Cancer Res Treat, 2023, 199, 371-379

Pérol, O ; Lepage, N ; Noelle, H ; Lebailly, P ; de Labrusse, B ; Clin, B & al , A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients., Int J Environ Res Public Health, 2023, 20,

Rogé, M ; Pointreau, Y ; Sargos, P ; Meyer, E ; Schick, U ; Hasbini, A & al , Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol., Clin Transl Radiat Oncol, 2023, 40, 100613

Féray, C ; Campion, L ; Mathurin, P ; Archambreaud, I ; Mirabel, X ; Bronowicki, JP & al , TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial., JHEP Rep, 2023, 5, 100689

Bergen, ES ; Pilla, L ; Auclin, E ; Ilhan-Mutlu, A ; Prager, GW ; Pietrantonio, F & al , Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study., Gastric Cancer, 2023, 26, 425-437

Blanc-Durand, F ; Yaniz-Galende, E ; Llop-Guevara, A ; Genestie, C ; Serra, V ; Herencia-Ropero, A & al , A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer., Gynecol Oncol, 2023, 171, 106-113

Constantinides, M ; Fayd » »herbe De Maudave, A ; Potier-Cartereau, M ; Campos-Mora, M ; Cartron, G ; Villalba, M , Direct Cell Death Induced by CD20 Monoclonal Antibodies on B Cell Lymphoma Cells Revealed by New Protocols of Analysis., Cancers (Basel), 2023, 15,

Gerard, JP ; Barbet, N ; Schiappa, R ; Magné, N ; Martel, I ; Mineur, L & al , Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial., Lancet Gastroenterol Hepatol, 2023, 8, 356-367

Tao, Y ; Sun, XS ; Pointreau, Y ; Le Tourneau, C ; Sire, C ; Kaminsky, MC & al , Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial., Eur J Cancer, 2023, 183, 24-37

Walter, T ; Lievre, A ; Coriat, R ; Malka, D ; Elhajbi, F ; Di Fiore, F & al , Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial., Lancet Oncol, 2023, 24, 297-306

Ferron, G ; De Rauglaudre, G ; Becourt, S ; Delanoy, N ; Joly, F ; Lortholary, A & al , Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial., Gynecol Oncol, 2023, 170, 186-194

Bello Roufai, D ; Gonçalves, A ; De La Motte Rouge, T ; Akla, S ; Blonz, C ; Grenier, J & al , Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program., Oncogene, 2023, 42, 1951-1956

Bailleux, C ; Arnaud, A ; Frenel, JS ; Chabaud, S ; Bachelot, T ; You, B & al , CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients., Breast Cancer, 2023, 30, 315-328

Tran, BT ; Gelin, A ; Durand, S ; Texier, M ; Daste, A ; Toullec, C & al, Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors., Oncoimmunology, 2023, 12, 2150472

Jiao, Y ; Truong, T ; Eon-Marchais, S ; Mebirouk, N ; Caputo, SM ; Dondon, MG & al , Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease., Eur J Cancer, 2023, 179, 76-86

Noverraz, F ; Robin, B ; Passemard, S ; Fauvel, B ; Presumey, J ; Rigal, E & al , Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody., Int J Pharm, 2023, 630, 122463

Vazquez, L ; Coussirou, J ; Grenier, J ; Billemont, B ; Mege, A ; de Rauglaudre, G & al , [Needs assessment for the establishment of an Oral Therapy Unit]., Bull Cancer, 2023, 110, 184-192

Aparicio, T ; Bouché, O ; Etienne, PL ; Barbier, E ; Mineur, L ; Desgrippes, R & al , Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial., Dig Liver Dis, 2023, 55, 541-548